INVESTIGATION ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm - GLIBA, VRTU, PRCP, WPX, EIDX

NEW YORK, Nov. 12, 2020 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating:

GCI Liberty, Inc. (NASDAQ: GLIBA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Liberty Broadband Corporation. If you are a GCI Liberty shareholder, click on this link to learn more about your legal rights and options: https://halpersadeh.com/actions/gci-liberty-inc-gliba-stock-merger-liberty-broadband-technologies/.

Virtusa Corporation (NASDAQ: VRTU) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to funds affiliated with Baring Private Equity Asia for $51.35 per share. If you are a Virtusa shareholder, click on this link to learn more about your rights and options:  https://halpersadeh.com/actions/virtusa-corporation-vrtu-stock-merger-baring-asia/.

Perceptron, Inc. (NASDAQ: PRCP) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Atlas Copco for $7.00 per share. If you are a Perceptron shareholder, click on this link to learn more about your rights and options: https://halpersadeh.com/actions/perceptron-inc-prcp-stock-merger-atlas-copco/.

WPX Energy, Inc. (NYSE: WPX) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Devon Energy Corporation for 0.5165 shares of Devon common stock for each share of WPX common stock. If you are a WPX Energy shareholder, click on this link to learn more about your legal rights and options: https://halpersadeh.com/actions/wpx-energy-inc-stock-merger-devon/.

Eidos Therapeutics, Inc. (NASDAQ: EIDX) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to BridgeBio Pharma, Inc.  Under the merger agreement, Eidos stockholders will receive either 1.85 shares of BridgeBio common stock or $73.26 in cash for each share of Eidos common stock owned. If you are an Eidos shareholder, click on this link to learn more about your rights and options: https://halpersadeh.com/actions/eidos-therapeutics-inc-eidx-stock-merger-bridgebio/.

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at [phone] or email [e-mail] or [e-mail].

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
[phone]
[e-mail]
[e-mail]  
https://www.halpersadeh.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/investigation-alert-halper-sadeh-llp-reminds-shareholders-about-its-ongoing-merger-investigations-investors-are-encouraged-to-contact-the-firm--gliba-vrtu-prcp-wpx-eidx-301172232.html

SOURCE Halper Sadeh LLP